Glycyrrhizin ameliorates insulin resistance, hyperglycemia, dyslipidemia and oxidative stress in fructose-induced metabolic syndrome-X in rat model

Indian Journal of Experimental Biology

Volumn 51, Issue 2, 2013, Pages 129-138

  Sil, Rajarshi ^a   Ray, Doel ^a,b   Chakraborti, Abhay Sankar ^a  

^a UNIVERSITY OF CALCUTTA   (India)

^b NATIONAL INSTITUTE OF PLANT GENOME RESEARCH   (India)

Author keywords

Glucose transporter 4; Glycation; High fructose diet; Insulin resistance; Metabolic syndrome; Peroxisome proliferator activated receptor

Indexed keywords

BIOLOGICAL MARKER; FRUCTOSE; GLUCOSE TRANSPORTER 4; GLYCYRRHIZIC ACID; HEMOGLOBIN; INSULIN; LIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SCAVENGER; SLC2A4 PROTEIN, RAT; TISSUE EXTRACT;

ANIMAL; ARTICLE; BLOOD; BODY WEIGHT; CHEMICALLY INDUCED DISORDER; DIET; DISEASE MODEL; DNA DAMAGE; DRUG EFFECT; DYSLIPIDEMIA; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; INSULIN RESISTANCE; LYMPHOCYTE; MALE; METABOLIC SYNDROME X; METABOLISM; MUSCLE; OXIDATIVE STRESS; RAT; WISTAR RAT;

ANIMALS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY WEIGHT; DIET; DISEASE MODELS, ANIMAL; DNA DAMAGE; DYSLIPIDEMIAS; FREE RADICAL SCAVENGERS; FRUCTOSE; GLUCOSE TRANSPORTER TYPE 4; GLYCYRRHIZIC ACID; HEMOGLOBINS; HYPERGLYCEMIA; INSULIN; INSULIN RESISTANCE; LIPIDS; LYMPHOCYTES; MALE; METABOLIC SYNDROME X; MUSCLES; OXIDATIVE STRESS; PPAR GAMMA; RATS; RATS, WISTAR; TISSUE EXTRACTS;

EID: 84873888969     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Eckel RH, Grundy SM & Zimmet PZ, The metabolic syndrome, Lancet, 365 (2005) 1415.
2. Nyenwe EA, Baddorf SW, Waters B, Wan JY & Solomon SS, Nonalcoholic fatty liver disease and metabolic syndrome in hypopituitary patients, Am J Med Sci, 338 (2009) 190.
3. Delbosc S, Paizanis E, Magous R, Araiz C, Dimo T, Cristol JP, Cros G & Azay J, Involvement of oxidative stress and NADPH oxidase activation in the development of cardiovascular complications in a model of insulin resistance, the fructose-fed rat, Atherosclerosis, 179 (2005) 43.
4. Dekker MJ, Su Q, Baker C, Rutledge AC & Adeli K, Fructose: A highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome, Am J Physiol Endocrinol Metab, 299 (2010) 685.
5. Gill H, Mugo M, Whaley-Connell A, Stump C & Sowers JR, The key role of insulin resistance in the cardiometabolic syndrome, Am J Med Sci, 330 (2005) 290.
6. Berger J, Biswas C, Vicario PP, Strout HV, Saperstein R & Pilch PF, Decreased expression of the insulin-responsive glucose transporter in diabetes and fasting, Nature, 340 (1989) 70.
7. Kuhlmann J, Neumann-Haefelin C, Belz U, Kalisch J, Juretschke HP, Stein M, Kleinschmidt E, Kramer W & Herling AW, Intramyocellular lipid and insulin resistance: a longitudinal in vivo 1H-spectroscopic study in Zucker diabetic fatty rats, Diabetes, 52 (2003) 138.
8. Shih CC, Lin CH, Lin WL & Wu JB, Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats, J Ethnopharmacol, 123 (2009) 82.
9. Takii H, Kometani T, Nishimura T, Nakae T, Okada S & Fushiki T, Antidiabetic effect of glycyrrhizin in genetically diabetic KK-Ay mice, Biol Pharm Bull, 24 (2001) 484.
10. Sen S, Roy M & Chakraborti AS, Ameliorative effect of glycyrrhizin on streptozotocin-induced diabetes in rats, J Pharm Pharmacol, 63 (2011) 287.
11. Kalaiarasi P & Pugalendi KV, Protective effect of 18β-glycyrrhetinic acid on lipid peroxidation and antioxidant enzymes in experimental diabetes, J Pharm Res, 4 (2011) 107.
12. Kalaiarasi P, Kaviarasan K & Pugalendi KV, Hypolipidemic effect of 18β-glycyrrhetinic acid on streptozotocin- induced diabetic rats, Eur J Pharmacol, 612 (2009) 93.
13. Kalaiarasi P & Pugalendi KV, Antihyperglycemic effect of 18β-glycyrrhetinic acid, aglycone of glycyrrhizin, on streptozotocin-diabetic rats Eur J Pharmacol, 606 (2009) 269.
14. Yin CY, Ha TS & Kadir KA, Effects of glycyrrhizic acid on peroxisome proliferator-activated receptor gamma (PPARγ), lipoprotein lipase (LPL), serum lipid and HOMA-IR in rats, PPAR Res, (2010) doi: 10.1155/2010/530265.
15. Eu CH, Lim WY, Ton SH & Kadir KA, Glycyrrhizic acid improved lipoprotein lipase expression, insulin sensitivity, serum lipid and lipid deposition in high-fat diet-induced obese rats, Lipids Health Dis, (2010) doi: 10.1186/1476- 511X-9-81.
16. Reitman S & Frankel S, A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases, Am J Clin Pathol, 28 (1957) 56.
17. Thambidorai D & Bachawat BK, Purification and properties of brain alkaline phosphatase, J Neurochem 29 (1977) 503.
18. Bergmeyer HU, Gawehn K & Grassl M, Enzymes as biochemical reagents, in Methods of Enzymatic Analysis (Academic Press, New York) 1974, 507.
19. Amador E & Wacker W, Serum glutamic oxalacetic transaminase activity. A new modification and an analytical assessment of current assay techniques, Clin Chem, 8 (1962) 343.
20. Ellman GL, Tissue sulphydryl groups, Arch Biochem Biophys, 82 (1959) 70.
21. Nandhini AT, Balakrishnan SD & Anuradha CV, Taurine improves lipid profile in rats fed a high fructose-diet, Nutr Res, 22 (2002) 343.
22. Bhattacharyya J, Bhattacharyya M, Chakraborti AS, Chaudhuri U & Poddar RK, Structural organisations of hemoglobin and myoglobin influence their binding behaviour with phenothiazines, Int J Biol Macromol, 23 (1998) 11.
23. Trinder P, Determination of glucose in blood using a glucose oxidase with an alternative oxygen acceptor, Ann Clin Biochem, 9 (1969) 24.
24. Friedewald WT, Levy RI & Fredrickson DS, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge, Clin Chem, 18 (1972) 499.
25. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia, 28 (1985) 412.
26. Murklund J & Murklund G, Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay of super oxide dismutase, Eur J Biochem, 47 (1974) 469.
27. Beers RF & Sizer IW, A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase, J Biol Chem, 195 (1952) 133.
28. Lowry OH, Rosebrough NJ, Farr AL & Randal RJ, Protein measurement with the Folin phenol reagents, J Biol Chem, 193 (1951) 265.
29. Yagi K, Lipid peroxides and human diseases, Chem Phys Lipids, 45 (1987) 337.
30. Johnson RN, Metcalf PA & Baker JR, Fructosamine: a new approach to the estimation of serum glycosylation. An index of diabetic control, Clinica Chimica Acta, 127 (1982) 87.
31. Panter SS, Release of iron from hemoglobin, Methods Enzymol, 231 (1994) 502.
32. Sadrzadeh SM, Graf E, Panter SS, Hallaway PE & Eaton JW, Hemoglobin. A biologic fenton reagent, J Biol Chem, 259 (1984) 14354.
33. Kar M & Chakraborti AS, Effect off glycosylation on ironmediated free radical reactions of hemoglobin, Current Science, 80 (2001) 770.
34. Gutteridge JMC, Iron promoters of the Fenton reaction and lipid peroxidation can be released from hemoglobin by peroxides, FEBS Lett, 201 (1986) 291.
35. Levine RC, Garland D, Oliver CN, Amiei A, Climent I, Lanz A, Ahn B, Shalleil SO & Stadtman ER, Determination of carbonyl content in oxidatively modified proteins, Methods Enzymol, 186 (1990) 464.
36. Wu JT, Tu MC & Zhung P, Advanced glycation end product (AGE): Characterization of the products from the reaction between D-glucose and serum albumin, J Clin Lab Anal, 10 (1998) 21.
37. Singh NP, McCoy MT, Tice RR & Schneider EL, A simple technique for quantitation of low levels of DNA damage in individual cells, Exp Cell Res, 175 (1998) 184.
38. Collins AR, Dusinka M, Franklin M, Somorovska M, Petrovska H, Fillion I, Pannayiotidis M, Raslova K & Vaughan N, Commet assay in human biomonitoring studies: Reliability, validation and application, Environ Mol Mutagen, 30 (1997) 139.
39. Lee YA, Cho EJ & Yokozawa T, Effects of proanthocyanidin preparations on hyperlipidemia and other biomarkers in mouse model of type 2 diabetes, J Agric Food Chem, 56 (2008) 7781.
40. Isbrucker RA & Burdock GA, Risk and safety assessment on the consumption of licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin, Regulatory Toxicol Pharmacol, 46 (2006) 167.
41. Yamamura Y, Santa T, Kotaki H, Uchino K, Sawada Y & Iga T, Administration-route dependency of absorption of glycyrrhizin in rats: intraperitoneal administration dramatically enhanced bioavailability, Biol Pharm Bull, 18 (1995) 337.
42. Zhai D, Zhao Y, Chen X, Guo J, He H, Yu Q, Yang J, Davey AK & Wang J, Protective effects of glycyrrhizin, glycyrrhetic acid and matrine on acute cholestasis induced by α-Napthyl Isothyocyanate in rats, Planta Med, 73 (2007) 1.
43. Guo L & Tabrizchi R, Peroxisome proliferator-activated receptor gamma as a drug target in the pathogenesis of insulin resistance, Pharmacol Ther, 111 (2006) 145.
44. Kar M & Chakraborti AS, Release of iron from hemoglobin - a possible source of free radicals in diabetes mellitus, Indian J Exp Biol, 37 (1999) 190.
45. Sen S, Kar M, Roy A & Chakraborti AS, Effect of nonenzymatic glycation on functional and structural properties of hemoglobin, Biophys Chem, 113 (2005) 289.
46. Roy M, Sen S & Chakraborti AS, Action of pelargonidin on hyperglycemia and oxidative damage in diabetic rats: Implication for glycation-induced hemoglobin modification, Life Sci, 82 (2008) 1102.
47. Halliwell B & Gutteridge JMC, Role of free radicals and catalytic metal ions in human disease, Methods Enzymol, 186 (1990) 1.